
Go-to-market Strategy
Go-to-market Strategy
-
Phase 1
Target agile practices in personalized and holistic longevity care.
Launch pilot programs with early adopters to generate case studies and real-world feedback.
-
Phase 2
Expand geographically into key markets in the US, Middle East, Europe, and Asia.
Establish strategic partnerships with insurers and wearable device manufacturers.
-
Phase 3
Scale into large healthcare systems and integrated care networks.
Diversification into drug and intervention development.
